Hello, Fool! | Login | Signup | My Fool
Nov 20, 2008 9:11 AM ET | Feedback | Site Changes | Help
The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.
View All Commentary (BIIB)
Recs
stanhutchings (< 20) Submitted: 8/26/06 12:54 AM : Start Price: $44.18 BIIB Score: 30.08
biotech pharma will be higher demand
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK